Ads

You May Also Like

NANOBIOTIX : 2016 review and 2017 anticipated milestones

   Nanobiotix: 2016 review and 2017 anticipated milestones Paris, France and Cambridge, Massachusetts, USA, January ...

Onconova Enrolls First Patient in Phase 3 INSPIRE Trial of Rigosertib

NEWTOWN, Pa., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage ...